A detailed history of Cohen Klingenstein LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cohen Klingenstein LLC holds 169,175 shares of PFE stock, worth $4.46 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
169,175
Previous 169,173 -0.0%
Holding current value
$4.46 Million
Previous $4.73 Million 3.42%
% of portfolio
0.18%
Previous 0.18%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$27.7 - $31.39 $55 - $62
2 Added 0.0%
169,175 $4.9 Million
Q2 2024

Jul 15, 2024

BUY
$25.26 - $29.6 $50 - $59
2 Added 0.0%
169,173 $4.73 Million
Q1 2024

Apr 12, 2024

SELL
$25.89 - $29.73 $1,346 - $1,545
-52 Reduced 0.03%
169,171 $4.69 Million
Q4 2023

Jan 12, 2024

BUY
$26.13 - $33.94 $52 - $67
2 Added 0.0%
169,223 $4.87 Million
Q3 2023

Oct 13, 2023

BUY
$32.09 - $37.51 $64 - $75
2 Added 0.0%
169,221 $5.61 Million
Q2 2023

Jul 14, 2023

BUY
$36.12 - $41.79 $72 - $83
2 Added 0.0%
169,219 $6.21 Million
Q1 2023

Apr 14, 2023

BUY
$39.39 - $51.28 $78 - $102
2 Added 0.0%
169,217 $6.9 Million
Q4 2022

Jan 13, 2023

BUY
$41.75 - $54.5 $8,391 - $10,954
201 Added 0.12%
169,215 $0
Q4 2021

Jan 14, 2022

SELL
$41.32 - $61.25 $709,877 - $1.05 Million
-17,180 Reduced 9.23%
169,014 $9.98 Million
Q3 2021

Oct 15, 2021

BUY
$39.25 - $50.42 $7,653 - $9,831
195 Added 0.1%
186,194 $8.01 Million
Q4 2019

Jan 15, 2020

BUY
$32.92 - $37.36 $451,004 - $511,832
13,700 Added 7.95%
185,999 $7.29 Million
Q2 2019

Jul 15, 2019

BUY
$36.98 - $41.52 $2.64 Million - $2.96 Million
71,364 Added 70.7%
172,299 $7.46 Million
Q1 2019

Apr 16, 2019

BUY
$37.5 - $41.2 $559,200 - $614,374
14,912 Added 17.33%
100,935 $4.29 Million
Q3 2017

Oct 17, 2017

BUY
$31.0 - $34.15 $2.67 Million - $2.94 Million
86,023
86,023 $3.07 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cohen Klingenstein LLC Portfolio

Follow Cohen Klingenstein LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cohen Klingenstein LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cohen Klingenstein LLC with notifications on news.